Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis

被引：0
|
作者：
Ploumen, R. [1 ,2 ]
Claassens, E. [1 ]
Kooreman, L. [2 ,3 ]
Keymeulen, K. [1 ]
van Kats, M. [4 ]
Gommers, S.
Siesling, S. [6 ,7 ]
van Nijnatten, T. [2 ,5 ]
Smidt, M. [1 ,2 ]
机构：
[1] Maastricht Univ, Surg, Med Ctr, Maastricht, Netherlands
[2] GROW, Sch Oncol & Reprod, Maastricht, Netherlands
[3] Maastricht Univ, Pathol, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Oncol, Med Ctr, Maastricht, Netherlands
[5] Maastricht Univ, Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands
[6] Univ Twente, Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands
[7] Netherlands Comprehens Canc Org, Res & Dev, Utrecht, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 175卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1LBA
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [41] ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials—Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy
    Susie X. Sun
    Henry M. Kuerer
    Annals of Surgical Oncology, 2019, 26 : 804 - 805
  • [42] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [43] Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis
    Niikura, Naoki
    Shimomura, Akihiko
    Fukatsu, Yumi
    Sawaki, Masataka
    Ogiya, Rin
    Yasojima, Hiroyuki
    Fujisawa, Tomomi
    Yamamoto, Mitsugu
    Tsuneizumi, Michiko
    Kitani, Akira
    Watanabe, Junichiro
    Matsui, Akira
    Takahashi, Yuko
    Takashima, Seiki
    Shien, Tadatoshi
    Tamura, Kenji
    Saji, Shigehira
    Masuda, Norikazu
    Tokuda, Yutaka
    Iwata, Hhiroji
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 81 - 87
  • [44] Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis
    Naoki Niikura
    Akihiko Shimomura
    Yumi Fukatsu
    Masataka Sawaki
    Rin Ogiya
    Hiroyuki Yasojima
    Tomomi Fujisawa
    Mitsugu Yamamoto
    Michiko Tsuneizumi
    Akira Kitani
    Junichiro Watanabe
    Akira Matsui
    Yuko Takahashi
    Seiki Takashima
    Tadatoshi Shien
    Kenji Tamura
    Shigehira Saji
    Norikazu Masuda
    Yutaka Tokuda
    Hhiroji Iwata
    Breast Cancer Research and Treatment, 2018, 167 : 81 - 87
  • [45] Durable complete response in HER2-positive breast cancer: A multicenter retrospective analysis
    Shimomura, A.
    Niikura, N.
    Fukatsu, Y.
    Sawaki, M.
    Ogiya, R.
    Yasojima, H.
    Fujisawa, T.
    Yamamoto, M.
    Tsuneizumi, M.
    Kitani, A.
    Watanabe, J.
    Matsui, A.
    Takahashi, Y.
    Takashima, S.
    Shien, T.
    Tamura, K.
    Saji, S.
    Masuda, N.
    Tokuda, Y.
    Iwata, H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes A Meta-Analysis
    Broglio, Kristine R.
    Quintana, Melanie
    Foster, Margaret
    Olinger, Melissa
    McGlothlin, Anna
    Berry, Scott M.
    Boileau, Jean-Francois
    Brezden-Masley, Christine
    Chia, Stephen
    Dent, Susan
    Gelmon, Karen
    Paterson, Alexander
    Rayson, Daniel
    Berry, Donald A.
    JAMA ONCOLOGY, 2016, 2 (06) : 751 - 760
  • [47] Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
    Mariani, Gabriella
    Fasolo, Angelica
    De Benedictis, Elena
    Gianni, Luca
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (02): : 93 - 104
  • [48] Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
    Gabriella Mariani
    Angelica Fasolo
    Elena De Benedictis
    Luca Gianni
    Nature Clinical Practice Oncology, 2009, 6 : 93 - 104
  • [49] Advances in systemic therapy for HER2-positive metastatic breast cancer
    Morrow, Phuong Khanh H.
    Zambrana, Francisco
    Esteva, Francisco J.
    BREAST CANCER RESEARCH, 2009, 11 (04):
  • [50] Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia
    Rodriguez, Mauricio
    Gonzalez, Diego M.
    El-Sharkawy, Farah
    Castano, Mileny
    Madrid, Jorge
    BIOMEDICA, 2023, 43 (03): : 396 - 405
12345